The company will produce the anti-HER3 antibody drug HMBD-001 for use within a clinical partnership between Cancer Research UK and Hummingbird Bioscience to test the agent in a Phase I trial. / read more /
advertisement
Subscribe
Subscribers can enjoy each full issue of Pharm Tech Europe in print, or via Pharm Tech Europe apps.
The successful inspection comes after the facility passed a pre-approval inspection in June 2019 from Japan's Pharmaceutical and Medical Device Agency for an innovative drug. / read more /
Dr. Reddy's, Sanofi, and Perrigo Company issued voluntary recalls of ranitidine in October 2019 because of N-Nitrosodimethylamine contamination. / read more /
The packaging solution works to protect drugs with a 3-Phase Activ-Polymer solution, a technology that is customized for the drug developer's formulation, offers a broad spectrum of specific drug protection, and oxygen and odor scavenging. / read more /
The therapy received positive results in a randomized, double-blind, placebo-controlled clinical trial in 34 adults with proven celiac disease. / read more /
Gerresheimer enlarged a cleanroom, installed a high-performance furnace, and automated testing and packaging systems for pharmaceutical glass packaging in Essen, Germany. / read more /
The editors explore novel technologies for the formulation, manufacture,
purification, and delivery of sterile small- and large-molecule drugs including single-use systems, facilities and equipment, contamination issues, and process analytics.
